Construction of focused library and the development of protein tyrosine phosphatase inhibitor
Construction of focused library and the development of protein tyrosine phosphatase inhibitor
批准号:
15310144
负责人:
SODEOKA Mikiko
金额:
$10.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
为了开发PTP(蛋白酪氨酸磷酸酶),合成了一个“聚焦文库”(具有“核心”结构的化合物,其可以作为磷酸模拟物与PTP的保守催化位点相互作用,并具有“各种”取代基,其可以与每种酶的独特区域相互作用)。研究了具有L-抗坏血酸作为“核心”结构的新文库的构建。我们已经开发了一种有效的方法,用于氨基甲酸酯的合成使用聚合物支撑的N-羟基琥珀酰亚胺(NHS)。使用这种方法合成了抗坏血酸-氨基甲酸酯库。氨基甲酸酯衍生物可以由6-氨基-抗坏血酸和各种醇制备,也可以由5-脱羟基-抗坏血酸和各种胺制备。对这些化合物(约80个化合物)进行了对PTP 1B(PTP)的抑制活性测试,其中有几个化合物表现出中等的抑制活性,并合成了第二代化合物库4-O-烷基化特窗酸衍生物,其中4-苄基-RK-682对乙酰肝素酶具有选择性抑制活性。4-苄基-RK-682对人纤维肉瘤HT 1060细胞的侵袭和迁移也有抑制作用。
英文摘要
Aiming at developing PTP (protein tyrosine phosphatase), a "focused-library" (compounds having a "core" structure that can interact with the conserved catalytic site of PTP as a phosphate mimic and having "various" substituents that may interact with the unique region of each enzyme) was synthesized. Construction of a new library having L-ascorbic acid as a "core" structure was examined. We have already developed an efficient method for carbamate synthesis using a polymer-supported N-hydroxysuccinimide (NHS). Using this method an ascorbic acid-carbamate library was synthesized. The carbamate derivatives were prepared either from 6-amino-ascorbic acid and various alcohols, or from 5-dehydroxy-ascorbic acid and various amines. The inhibitory activity of these compounds (about 80 compounds) toward PTP1B (PTP) was tested, and several compounds showed the moderate inhibitory activity.The 4-O-alkyated tetronic acid derivatives as second generation library was synthesized, and 4-benzyl-RK-682 has been found to possess a selective inhibitory activity for heparanase. 4-Benzyl-RK-682 also inhibited the invasion and migration of human fibrosarcoma HT 1060 cells.The isobenzofuranone library was also synthesized, and among them we have found the strong PKCα activators.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Y.Baba, S.Mayumi, G.Hirai, H.Kawasaki, Y.Ogoshi, T.Yanagisawa, Y.Hashimoto, M.Sodeoka: "Evaluation of Series of Isobenzofuranone Dimers as PKCa Ligands : Implication for the Distance between the Two Ligand Binding Sites"Bioorg.Med.Chem.Lett.. Vol.14(In Pr
Y.Baba、S.Mayumi、G.Hirai、H.Kawasaki、Y.Ogoshi、T.Yanagisawa、Y.Hashimoto、M.Sodeoka:“一系列异苯并呋喃酮二聚体作为 PKCa 配体的评估:对两者之间距离的影响
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1016/j.tetlet.2005.01.018
发表时间:
2005-02
期刊:
Tetrahedron Letters
影响因子:
1.8
作者:
[Y. Hamashima;Toshiaki Suzuki;Yuta Shimura;Tadashi Shimizu;N. Umebayashi;Toshihiro Tamura;Naoki Sasamoto;M. Sodeoka]
通讯作者:
Y. Hamashima;Toshiaki Suzuki;Yuta Shimura;Tadashi Shimizu;N. Umebayashi;Toshihiro Tamura;Naoki Sasamoto;M. Sodeoka
DOI:
10.1016/j.bmcl.2004.02.097
发表时间:
2004-06-07
期刊:
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
影响因子:
2.7
作者:
[Baba, Y, Ogoshi, Y, Sodeoka, M]
通讯作者:
Sodeoka, M
Y.Baba, Y.Ogoshi, G.Hirai, T.Yanagisawa, K.Nagamatsu, S.Mayumi, Y.Hashimoto, M.Sodeoka: "Design, Synthesis, and Structure-Activity Relationship of New Isobenzofuranone Ligands of Protein Kinase C."Bioorg.Med.Chem.Lett.. Vol.14(In Press). (2004)
Y.Baba、Y.Ogoshi、G.Hirai、T.Yanagisawa、K.Nagamatsu、S.Mayumi、Y.Hashimoto、M.Sodeoka:“蛋白激酶 C 新型异苯并呋喃酮配体的设计、合成和构效关系
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1158/1535-7163.1069.3.9
发表时间:
2004-09
期刊:
Molecular cancer therapeutics
影响因子:
5.7
作者:
[K. Ishida;Go Hirai;K. Murakami;T. Teruya;S. Simizu;M. Sodeoka;H. Osada]
通讯作者:
K. Ishida;Go Hirai;K. Murakami;T. Teruya;S. Simizu;M. Sodeoka;H. Osada
共 10 条
Clarification research for molecular mechanism of a novel type of protein kinase C inhibitor
-
批准号:21603016
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:SODEOKA Mikiko
-
依托单位:
海外基金